140 related articles for article (PubMed ID: 3997592)
1. Recurrent stage I endometrial carcinoma: results of treatment and prognostic factors.
Mandell LR; Nori D; Hilaris B
Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1103-9. PubMed ID: 3997592
[TBL] [Abstract][Full Text] [Related]
2. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
[TBL] [Abstract][Full Text] [Related]
3. [Recurrence of stage I endometrial cancer: effect of prognostic factors on therapeutic results].
Vavra N; Kucera H; Weghaupt K
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):267-71. PubMed ID: 1860659
[TBL] [Abstract][Full Text] [Related]
4. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
[TBL] [Abstract][Full Text] [Related]
5. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
[TBL] [Abstract][Full Text] [Related]
6. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
7. Endometrial carcinoma: stage I. A retrospective analysis of 262 patients.
De Palo G; Kenda R; Andreola S; Luciani L; Musumeci R; Rilke F
Obstet Gynecol; 1982 Aug; 60(2):225-31. PubMed ID: 7155485
[TBL] [Abstract][Full Text] [Related]
8. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
9. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
[TBL] [Abstract][Full Text] [Related]
10. Prognostic variables in endometrial carcinoma.
Poulsen MG; Roberts SJ
Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):1043-52. PubMed ID: 3597147
[TBL] [Abstract][Full Text] [Related]
11. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
14. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
15. Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system.
Curran WJ; Whittington R; Peters AJ; Fanning J
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):803-8. PubMed ID: 3182319
[TBL] [Abstract][Full Text] [Related]
16. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
17. The salvage of recurrent endometrial carcinoma in the vagina and pelvis.
Poulsen MG; Roberts SJ
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):809-13. PubMed ID: 3182320
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
[TBL] [Abstract][Full Text] [Related]
19. Management of early stage endometrial papillary adenocarcinoma.
Ampil F; Ridenour C; Abreo F
J La State Med Soc; 1991 Jan; 143(1):22-7. PubMed ID: 2002268
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma.
Demopoulos RI; Dubin N; Noumoff J; Blaustein A; Sommers GM
Obstet Gynecol; 1986 Aug; 68(2):245-50. PubMed ID: 3737041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
